Joe Rogan's Discussed Stack
Podcaster, Onnit backer
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (educational content)
Reference only. Not medical advice.
What can go wrong
As the dominant amplifier, he broadcasts guests' supplement/hormone claims to a massive audience; some amplified products (Onnit/Alpha Brain) were ones he profited from directly via equity.
This is something to take to a clinician. The Atlas can tell you what is known about joe rogan's discussed stack in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Joe Rogan doesn't originate protocols but broadcasts them to the largest podcast audience in the world. He openly discloses being on physician-supervised TRT (and ~1 IU/day HGH), and amplifies guests' natural-T advice (notably Huberman's tongkat ali/fadogia stack and Paul Saladino's animal-based claims). His key conflict: he was an early backer and part-owner of Onnit and promoted Alpha Brain for years, and he is a paid AG1 sponsor.
The biggest amplifier, openly on TRT, with an Onnit equity stake.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often saidRogan's recommendations are just personal opinion
ActuallyHe held equity in Onnit while promoting Alpha Brain and is a paid AG1 sponsor, material financial interests behind some of what he amplifies. His TRT use is disclosed personal use, not a paid endorsement.
Who profits, and who pushes back
Joe Rogan
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Onnit early investor/part-owner; AG1 paid sponsor (~$10M/yr reported). TRT/HGH are disclosed personal use.
At a glance
- Platform
- The Joe Rogan Experience
- TRT
- Openly disclosed (physician-supervised)
- Owns/backed
- Onnit (part-owner); AG1 sponsor
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Joe Rogan's Discussed Stack. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.